株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ノミおよびダニ対策用品の世界市場 - 成長性、動向、および将来予測

Global Flea and Tick Product Market - Segmented by Product, Animal, and Geography - Growth, Trends, and Forecast (2018 - 2023)

発行 Mordor Intelligence LLP 商品コード 704730
出版日 ページ情報 英文 109 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.75円で換算しております。
Back to Top
ノミおよびダニ対策用品の世界市場 - 成長性、動向、および将来予測 Global Flea and Tick Product Market - Segmented by Product, Animal, and Geography - Growth, Trends, and Forecast (2018 - 2023)
出版日: 2018年07月01日 ページ情報: 英文 109 Pages
概要

当レポートでは、動物やペット用のノミおよびダニ対策用品の世界市場を取り上げ、市場の成長促進要因、阻害要因、市場機会、また市場競争状況の広範な調査に基づいて現行市場の分析と将来予測とを行っています。さらに当レポートでは、この市場を製品別、動物別、および地域別に分類し、それぞれ詳細な分析・予測を提供しています。

第1章 序論

  • 市場の定義

第2章 調査手法

第3章 エグゼクティブ・サマリー

第4章 重要な結論

第5章 市場概要

  • 現行市場シナリオ
  • Porterのファイブフォース分析
    • 売り手の交渉力
    • 買い手の交渉力
    • 新規参入企業がもたらす脅威
    • 代替品および代替サービスがもたらす脅威
    • 企業間の競合関係

第6章 市場ダイナミクス

  • 市場の成長促進要因
  • 市場の成長阻害要因
  • 市場機会
  • 主な課題

第7章 市場分類

  • 製品別分類
    • 経口錠剤
    • スプレー
    • 滴下薬
    • 粉薬
    • シャンプー
    • 首輪
    • その他 (注射薬、液剤)
  • 動物別分類
    • 他 (ネズミ、ウサギ等)
  • 地域別分類
    • 北米
    • 欧州
    • アジア太平洋
    • 中東およびアフリカ
    • 南米

第8章 市場競争状況

  • 企業吸収合併分析
  • 業務協定、協業、および企業提携
  • 新製品投入

第9章 主要企業

  • Bayer AG
  • Ceva
  • Ecto Development Corporation
  • Elanco
  • Intervet Inc.
  • Merial Inc.
  • Sergeant's Pet Care Products, Inc.
  • The Hartz Mountain Corporation
  • Virbac
  • Wellmark International

第10章 市場の将来

目次
Product Code: 62886

The Flea and Tick Product Market is expected to register a growth rate of approximately 4.9% during the forecast period, 2018-2023. Flea and Tick Products refer to various chemicals, drugs and equipment which prevent infestation with flea and tick in animals as well as cure the diseases caused by those parasites. The market is primarily driven by rise in prevalence of flea and tick-transmitted diseases in pets, growth in awareness about zoonotic diseases caused by flea and tick bites and product innovation. As per the geographical analysis, North America followed by Europe are expected to dominate the market, while Asia-Pacific is expected to exhibit fastest growth rate owing to the factors such as rise in awareness about animal health and ongoing biomedical advances regarding treatment of various animal diseases.

Rise in Prevalence of Flea and Tick Transmitted Diseases in Pets to Propel the Flea and Tick Product Market

Rising prevalence of flea and tick-borne diseases in animals owing to the fact that these ectoparasites not only cause skin allergies and infections, but also transmit several diseases such as bubonic plague, murine typhus, ehrlichiosis, Rocky Mountain spotted fever, Lyme disease, tularemia, tungiasis, and anaplasmosis, is expected to propel the market growth. A report published by Centers for Disease Control and Prevention states that, during the 13 years from 2004 through 2016, diseases caused by tick, and flea bites have tripled in the U.S., with more than 640,000 cases reported. The report states that 96,075 disease cases have been reported in 2016 among which 26,203 were only for Lyme disease, while the total number was near to 55,000 in 2015. Similarly, according to the parasite prevalence map published by Pets and Parasites, the prevalence of anaplasmosis, ehrlichiosis and Lyme disease in US in the year 2017 have been estimated to be 3.85%, 3.04%, and 6.27% respectively.

Hence the increase in the number of pets getting infected by a variety of flea and tick-borne diseases and thus rise in the necessity of them being treated are expected to contribute to the growth of the market. In addition to the aforementioned factor, increase in awareness about pets' health as well as various zoonotic diseases caused by flea and tick bites and product innovation are expected to propel the market growth over the forecast period.

Side Effects Associated with the Treatment to Limit the Market Growth

Various side effects ranging from external effects such as skin irritation, hair loss, to the internal impacts such as severe neurological disorders, associated with the flea and tick products are expected to restrain the market growth. The common side effects associated with flea and tick treatment medicines include rash, redness, loss of hair, itching with discoloration, drooling, increased excitability, changes in body temperature (lower or higher), tremors, vomiting, diarrhea, lack of coordination, seizures, and lethargy. Research by EPA's (the United States Environmental Protection Agency) Pesticide Division has found that the animal body retains the active ingredient (fipronil) present in Frontline with the potential for intoxicating nervous and thyroid system. The tests performed on laboratory animals resulted in thyroid cancer and altered thyroid hormones, liver and kidney toxicity, reduced fertility and convulsions. The study also shows that instead of staying just in the oil glands, the ingredient enters the body and the organ systems. Similarly, other in vitro studies indicate that another insecticide, Imidacloprid, increases cholesterol levels in dogs, creates liver toxicity, causes thyroid lesions, and potentially damages the liver, heart, lungs, spleen, adrenals, brain, and gonads. Being a neurotoxin, it can cause incoordination along with muscle weakness and labored breathing. Additional, in another report published in the Journal of Pesticide Reform, imidacloprid has been found to cause thyroid lesions. As a result of this, the reluctance of pet owners to apply any flea and tick treatment product on their pet animals is expected to restrain the Flea and Tick Product market. Hence, impeding the market growth.

North America to Dominate the Flea and Tick Product Market

North America is expected to retain its dominance in Flea and Tick Product Market over the forecast period owing to the increasing companion animal adoption, growing disposable income and rising per capita animal healthcare expenditure. In addition, growing awareness about pet health among the pet owners, and rise in product innovation such as new formula launches are some other major factors for driving the growth of the Flea and Tick Product Market in North America.

Europe being the second largest market for Flea and Tick Product is expected to follow North America, while Asia-Pacific is expected to demonstrate highest growth rate owing to factors such as increasing awareness about parasitic diseases of pets, and pest management for the host animals. Hence, the aforementioned factors are expected to fuel the growth of the Flea and Tick Product Market in the Asia.

Key Developments in the Market

Mar 2018 - Ceva Animal Health launches Duoflect, a new spot on, that contains a new formulation of fipronil and (s)-methoprene offering 100% longer duration of action against fleas in cats (eight weeks), and 13% longer duration in dogs (nine weeks) than the fipronil combination.

Jun 2018 - Elanco Animal Health announces U.S. Food and Drug Administration (FDA) approval of Credelio (Lotilaner), an oral drug to treat and give protection against ticks and fleas.

Major Players - BAYER AG, CEVA, ECTO DEVELOPMENT CORPORATION, ELANCO, INTERVET INC., MERIAL INC., SERGEANT'S PET CARE PRODUCTS, INC., THE HARTZ MOUNTAIN CORPORATION, VIRBAC, and WELLMARK INTERNATIONAL among others.

Reasons to Purchase the Report

The current and future outlook of the global surgical microscopes market in the developed and emerging markets

Analysis of various perspectives of the market with the help of Porter's five forces analysis

The segment that is expected to dominate the market

Regions that are expected to witness the fastest growth during the forecast period

Identify the latest developments, market shares, and strategies employed by the major market players

3-month analyst support, along with the market estimate sheet (in Excel)

Customization of the report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitute Products and Services
    • 5.2.5 Competitive Rivalry within the Industry

6. Market Dynamics

  • 6.1 Market Drivers
    • 6.1.1 Rise in Prevalence of Flea and Tick Transmitted Diseases in Pets
    • 6.1.2 Growth in Awareness about Zoonotic Diseases caused by Flea and Tick Bites
    • 6.1.3 Product Innovation
  • 6.2 Market Restraints
    • 6.2.1 Side Effects Associated with the Treatment
    • 6.2.2 Availability of Counterfeit Pesticide Products for Pets
  • 6.3 Market Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 By Product
    • 7.1.1 Oral Pill
    • 7.1.2 Spray
    • 7.1.3 Spot On
    • 7.1.4 Powder
    • 7.1.5 Shampoo
    • 7.1.6 Collar
    • 7.1.7 Others (Injection, Drops, Dips)
  • 7.2 By Animal
    • 7.2.1 Dogs
    • 7.2.2 Cats
    • 7.2.3 Others (Mice, Rabbits etc.)
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 United States
      • 7.3.1.2 Canada
      • 7.3.1.3 Mexico
    • 7.3.2 Europe
      • 7.3.2.1 France
      • 7.3.2.2 Germany
      • 7.3.2.3 United Kingdom
      • 7.3.2.4 Italy
      • 7.3.2.5 Spain
      • 7.3.2.6 Rest of Europe
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 China
      • 7.3.3.2 Japan
      • 7.3.3.3 India
      • 7.3.3.4 Australia
      • 7.3.3.5 South Korea
      • 7.3.3.6 Rest of Asia-Pacific
    • 7.3.4 Middle East & Africa
      • 7.3.4.1 GCC
      • 7.3.4.2 South Africa
      • 7.3.4.3 Rest of Middle East & Africa
    • 7.3.5 South America
      • 7.3.5.1 Brazil
      • 7.3.5.2 Argentina
      • 7.3.5.3 Rest of South America

8. Competitive Landscape

  • 8.1 Merger & Acquisition Analysis
  • 8.2 Agreements, Collaborations, and Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 Bayer AG
  • 9.2 Ceva
  • 9.3 Ecto Development Corporation
  • 9.4 Elanco
  • 9.5 Intervet Inc.
  • 9.6 Merial Inc.
  • 9.7 Sergeant's Pet Care Products, Inc.
  • 9.8 The Hartz Mountain Corporation
  • 9.9 Virbac
  • 9.10 Wellmark International

List Not Exhaustive

10. Future of the Market

Back to Top